| Product NDC: | 45802-021 |
| Proprietary Name: | Betamethasone Dipropionate |
| Non Proprietary Name: | Betamethasone Dipropionate |
| Active Ingredient(s): | .5 mg/g & nbsp; Betamethasone Dipropionate |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | LOTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 45802-021 |
| Labeler Name: | Perrigo New York Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA072538 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20060630 |
| Package NDC: | 45802-021-46 |
| Package Description: | 1 BOTTLE, PLASTIC in 1 CARTON (45802-021-46) > 56.2 g in 1 BOTTLE, PLASTIC |
| NDC Code | 45802-021-46 |
| Proprietary Name | Betamethasone Dipropionate |
| Package Description | 1 BOTTLE, PLASTIC in 1 CARTON (45802-021-46) > 56.2 g in 1 BOTTLE, PLASTIC |
| Product NDC | 45802-021 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Betamethasone Dipropionate |
| Dosage Form Name | LOTION |
| Route Name | TOPICAL |
| Start Marketing Date | 20060630 |
| Marketing Category Name | ANDA |
| Labeler Name | Perrigo New York Inc |
| Substance Name | BETAMETHASONE DIPROPIONATE |
| Strength Number | .5 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |